Sal Daher, CFA

Daily briefing: Merck downgrades COVID pill results

Merck’s oral COVID drug appears to be less effective than originally thought. Plus, promising vaccines for the respiratory virus RSV, and the most stunning science photos of the year. Merck’s oral COVID drug appears to be less effective than originally thought. Plus, promising vaccines for the respiratory virus RSV, and the most stunning science photos of the year.